Pham Quang X 4
4 · Cadrenal Therapeutics, Inc. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
Cadrenal (CVKD) 10% Owner Pham Quang X Sells Shares
What Happened
Pham Quang X, a reported 10% owner of Cadrenal Therapeutics, sold a total of 17,124 shares in three open-market transactions between June 11 and June 15, 2026, generating approximately $70,351 in proceeds. The individual transactions were: 1,462 shares at a weighted average price of $4.12 (≈ $6,023), 12,996 shares at $3.94 (≈ $51,204), and 3,666 shares at $3.58 (≈ $13,124). These sales were made under a pre-established Rule 10b5-1 trading plan.
Key Details
- Transaction dates & weighted-average prices:
- 2026-06-11: 1,462 shares @ $4.12 (range reported 4.09–4.16)
- 2026-06-12: 12,996 shares @ $3.94 (range reported 3.80–4.23)
- 2026-06-15: 3,666 shares @ $3.58 (range reported 3.22–3.81)
- Total shares sold: 17,124; total proceeds: ≈ $70,351.
- Trading plan: Sales executed pursuant to a Rule 10b5-1 plan adopted September 25, 2025.
- Ownership note: Quang Pham is trustee of The PVBQ Living Trust and has sole voting and dispositive power over trust shares; the trust’s sole beneficiary is his child.
- Filing: Form 4 filed 2026-06-15 (Accession 0001213900-26-068981) covering transactions through 2026-06-15. The filing appears timely based on the transaction dates.
- Shares owned after transaction: not disclosed in the provided excerpt.
Context
These were outright sales by a 10% owner under a pre-set trading plan; such transactions are often routine and governed by plan parameters rather than immediate market views. For retail investors, purchases typically carry stronger signals than routine, pre-scheduled sales.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-11$4.12/sh−1,462$6,023→ 149,377 total - Sale
Common Stock
[F1][F3]2026-06-12$3.94/sh−12,996$51,204→ 136,381 total - Sale
Common Stock
[F1][F4]2026-06-15$3.58/sh−3,666$13,124→ 132,715 total
- 200,000(indirect: By Trust)
Common Stock
[F5]
Footnotes (5)
- [F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.09 through $4.16. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 through $4.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.22 through $3.81. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and dispositive power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.